Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7132116
SERIAL NO

10640403

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to the use of arsenic compounds to treat a variety of neoplastic diseases. The present invention encompasses the administration to a mammal of arsenic in the form of a salt, complex, organic compound or ionic solution to treat tumors of epithelial tissue, connective tissue, central nervous system, lymphoid tissue, hematopoietic cells and tumors associated with oncogenic viruses. This invention also encompasses the treatment of hematopoietic disorders in mammals by the administration of one or more arsenic compounds to said mammal. Further, the arsenic compounds may be used to treat metastatic neoplastic diseases.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • POLARX BIOPHARMACEUTICALS, INC.

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ellison, Ralph M Palm Beach, FL 9 33
Mermelstein, Fred H Clifton, NJ 26 245

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation